VanEck Associates’s Archrock AROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.85M Buy
192,835
+112,002
+139% +$4.12M ﹤0.01% 700
2026
Q1
$2.81M Buy
80,833
+22,692
+39% +$724K ﹤0.01% 925
2025
Q4
$1.51M Buy
58,141
+6,164
+12% +$153K ﹤0.01% 1034
2025
Q3
$1.37M Sell
51,977
-12,814
-20% -$309K ﹤0.01% 1042
2025
Q2
$1.61M Buy
64,791
+1,946
+3% +$47.7K ﹤0.01% 981
2025
Q1
$1.65M Buy
62,845
+24,218
+63% +$653K ﹤0.01% 976
2024
Q4
$961K Sell
38,627
-29,624
-43% -$686K ﹤0.01% 1040
2024
Q3
$1.38M Buy
68,251
+32,971
+93% +$668K ﹤0.01% 960
2024
Q2
$713K Buy
35,280
+753
+2% +$14.9K ﹤0.01% 1031
2024
Q1
$679K Buy
34,527
+6,414
+23% +$110K ﹤0.01% 1028
2023
Q4
$433K Buy
28,113
+1,624
+6% +$22.6K ﹤0.01% 1069
2023
Q3
$334K Sell
26,489
-1,120
-4% -$13.4K ﹤0.01% 1095
2023
Q2
$283K Buy
27,609
+8,376
+44% +$82.6K ﹤0.01% 1127
2023
Q1
$188K Buy
+19,233
New +$189K ﹤0.01% 1172
2022
Q3
Sell
-25,977
Closed -$215K 1387
2022
Q2
$215K Sell
25,977
-369
-1% -$3.38K ﹤0.01% 1060
2022
Q1
$243K Buy
+26,346
New +$226K ﹤0.01% 1069

Other funds holding AROC

VanEck Associates's AROC Position: Q2 2026 in Review

VanEck Associates increased its Archrock (AROC) stake by 139% in Q2 2026, buying an estimated $4.12M and bringing the position to 192,835 shares worth $7.85M. The position accounts for ﹤0.01% of the portfolio, ranked #700.

VanEck Associates first reported a position in AROC in Q1 2022 and has held it in 16 quarters since. 450 funds tracked by Wall St. Rank hold AROC as of Q2 2026.

  • VanEck Associates held 192,835 shares of Archrock worth $7.85M as of Q2 2026.
  • VanEck Associates bought 112,002 Archrock shares in Q2 2026, an estimated $4.12M.
  • Archrock made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #700 holding.
  • VanEck Associates first reported a position in Archrock in Q1 2022 and has held it in 16 quarters since.
  • 450 funds tracked by Wall St. Rank held Archrock as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.